Fundz

Finnish AQ BioTech raises €2.5M in seed funding to expand cancer screening technology into China.

PRIVATESep 10, 2026

Amount Raised

€2.5 Million

Round Type

Seed

FinlandBiotechnologyHealth Care

Description

AQ BioTech, a Finnish biotechnology company, has closed a €2.5 million seed funding round to support its international expansion and technology development. The capital will enable the company to scale its next-generation biomarker discovery platform and establish partnerships in China. AQ BioTech develops technology for biomarker discovery to support drug development and personalized healthcare approaches. The funding reflects growing Nordic interest in targeting China's biotechnology sector.

Quick answer

AQ BioTech raised €2.5 Million in a Seed round, dated September 10, 2026. AQ BioTech is based in Finland.

How much did AQ BioTech raise?
AQ BioTech raised €2.5 Million in a Seed round on September 10, 2026.
What does AQ BioTech do?
AQ BioTech is a Finnish biotechnology company that develops technology for biomarker discovery to identify biological indicators linked to diseases and health conditions.
Where is AQ BioTech based and how big is it?
AQ BioTech is based in Finland. Fundz records about 13 employees.
Who are the decision-makers at AQ BioTech?
Fundz holds 2 contacts at AQ BioTech, including the Chief Business Officer and Co-owner. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as AQ BioTech that raised within 45 days of this round, from Fundz verified event records.

  • Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
  • Pathos AI raised $237M (Series E) on October 23, 2026.
  • Zai Lab Limited raised $250M (Post-IPO Equity) on October 23, 2026.
  • Trior raised $25M (Series C) on October 23, 2026.
  • MedEnvision raised an undisclosed amount on October 22, 2026.
  • Familiar Therapeutics raised $5M (Seed) on October 22, 2026.

Who to call at AQ BioTech, and when

A new round usually means AQ BioTech is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day AQ BioTech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AQ BioTech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AQ BioTech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AQ BioTech

Location

Finland

About

AQ BioTech is a Finnish biotechnology company that develops technology for biomarker discovery to identify biological indicators linked to diseases and health conditions. The company's technology supports drug development and enables more personalized approaches to healthcare. AQ BioTech is expanding internationally with a focus on the Chinese market to develop partnerships and grow its presence in the biotechnology sector.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AQ BioTech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJukka H., Chief Business Officer and Co-owner hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for AQ BioTech's next move

See what Strategic adds

AQ BioTech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.